|
|
|
| About Us / People / Executive Management
|
Executive Management | 
| | Professor Mark Ferguson
Co-Founder and CEO |
Professor Mark Ferguson is the co-founder and Chief Executive Officer of Renovo and has been responsible for building and leading all aspects of the business since its inception. He holds a number of international prizes for research in wound healing and scarring including the 2002 European Science Prize. He has published more than 350 scientific papers, books, book chapters and patents and has more than 30 years of experience in biomedical research including developmental biology, regenerative medicine, wound healing and scarring.
Mark has served as President and Secretary of the European Tissue Repair Society, was a member of MHRA's Safety of Medicines Biologics sub-committee and has served as a member of Government committees including chairing the UK Government Foresight Committee on Health and Life Sciences. He is currently President of the Manchester Medical Society and a member of the UKTI Life Sciences Marketing Board.
Mark was a Professor at the University of Manchester from 1986-2007 where he served as Head of Department, Dean of Biological Sciences and lead a large research group. He now holds an honorary Professorship at the University of Manchester. He also founded, chaired and was CEO of Manchester Biotec Ltd, a university company formed to foster promising new biotechnology ventures. During this time he was responsible for funding, building and staffing its £15 million Incubator Building and raising a £10 million investment seed fund.
Professor Ferguson has doctorate degrees in Anatomy, Dentistry and Medical Sciences, honorary fellowships of the Royal College of Surgeons in Ireland and Edinburgh and is founding fellow of the UK Academy of Medical Science. He was made a Commander of the British Empire in 1999. |
|
|
|
|
